This inventor holds 2 USPTO granted patents. Top assignee: University of Utah Research Foundation. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Innovations of Binxun Yu in Cancer Treatment
Introduction
Binxun Yu is a notable inventor based in Lanzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target protein-protein interactions associated with various tumors and cancers. With a total of 2 patents, his work is paving the way for new therapeutic approaches.
Latest Patents
Yu's latest patents include innovative compounds such as substituted 1H-indazol-1-OL analogs. These compounds serve as inhibitors of beta catenin/Tcf protein-protein interactions. The invention encompasses synthetic methods for creating these compounds, pharmaceutical compositions that include them, and methods for treating disorders linked to beta-catenin/Tcf dysfunction. This research aims to address various tumors and cancers, showcasing the potential of these compounds in therapeutic applications.
Career Highlights
Binxun Yu is affiliated with the University of Utah Research Foundation, where he continues to advance his research in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for serious health conditions.
Collaborations
Yu collaborates with esteemed colleagues such as Haitao Ji and Wenxing Guo, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Binxun Yu's contributions to cancer treatment through his innovative patents highlight the importance of research in developing new therapeutic options. His work exemplifies the potential impact of scientific advancements on healthcare.